SCHEMBL18274745

SCHEMBL18274745

O=C(NS(=O)(=O)c1ccc(NCCCN2CCOCC2)c(S(=O)(=O)C(F)(F)F)c1)c1ccc(N2CCN(Cc3cc(Cl)ccc3-c3ccccc3)CC2)cc1Oc1cccc2[nH]ccc12

nearest known ligand 0.90

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ BCL2 P10415 4/20 0.62

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1957165 0.94 BCL2 (0.70) BCL2
SCHEMBL19424739 0.86 BCL2 (0.73) BCL2
SCHEMBL19424679 0.86 BCL2 (0.68) BCL2
SCHEMBL1956264 0.86 BCL2 (0.75) BCL2
SCHEMBL19424618 0.85 BCL2 (0.71) BCL2
SCHEMBL1955951 0.85 BCL2 (0.84) BCL2
SCHEMBL1957005 0.85 BCL2 (0.71) BCL2
SCHEMBL2829322 0.78 BCL2 (0.70) BCL2
SCHEMBL19424900 0.78 BCL2 (0.66) BCL2
SCHEMBL19424731 0.78 BCL2 (0.79) BCL2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3101019-A1 SULFONAMIDE DERIVATIVES AS BCL-2-SELECTIVE APOPTOSIS-INDUCING AGENTS FOR THE TREATMENT OF CANCER AND IMMUNE DISEASES AbbVie Inc. (US) 2016-12-07 — — EP disclosed
Send feedback